AC Immune’s Mixed Phase II Results Buoy Alzheimer’s Research
An Alzheimer’s disease drug developed by AC Immune and Genentech has drawn conflicting phase II…
02/09/2021 - 5 minutes
AC Immune
A Year to Remember: The Biggest European Biotech News in 2020
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled…
28/12/2020 - 12 minutes
Eli Lilly Sweetens AC Immune Alzheimer’s Treatment Deal by €38M
A deal between Swiss biotech AC Immune and Eli Lilly to develop an oral Alzheimer’s…
24/03/2020 - 3 minutes
AC Immune Gets €28M from Eli Lilly as Alzheimer’s Drug Hits Phase I
AC Immune will receive €27.6M (CHF 30M) from big pharma Eli Lilly as it begins…
23/09/2019 - 2 minutes
The Top 20 Women in Leading Biotech Roles in Europe
The biotech industry has often been criticized for its lack of gender diversity. While there…
21/05/2019 - 12 minutes
Top 10 Biotechs in Lausanne
The Swiss city of Lausanne is perhaps best known as a hub of international sport,…
08/05/2019 - 7 minutes
Say Hello to the Top 14 Entrepreneurial Women in European Biotech
Today, March 8, is international women's day. To celebrate the achievements of women we're revisiting…
08/03/2018 - 8 minutes
Happy 2018, Here Are the Top 9 European Biotech Companies To Watch
As the 2017 reports roll in, we're already turning our gaze to 2018. These are…
09/01/2018 - 5 minutes
Meet the Swiss CEO Pulling Out All the Stops Against Alzheimer’s Disease
Efforts to treat Alzheimer’s Disease have been hit with failure after failure in the last…
08/01/2018 - 8 minutes
Swiss Biotech Gets €12M as its Alzheimer’s Candidate Enters Phase II
AC Immune's Anti-Tau antibody for the treatment of Alzheimer's disease has reached Phase II, prompting…
02/11/2017 - 2 minutes
German Biotech Unveils Positive Phase II Results for Alzheimer’s
Probiodrug has disclosed encouraging results of its latest Phase IIa trial to assess its lead…
12/06/2017 - 3 minutes
Hopes are up: A Second Phase III Trial for Alzheimer’s Disease
The Swiss biotech AC Immune announced that its partner Genentech (Roche) will start a second phase…
28/02/2017 - 3 minutes
